Literature DB >> 27823827

The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system.

Jens Wilkens1, Hans Thulesius2, Ingrid Schmidt3, Christina Carlsson4.   

Abstract

Starting in 2015, the Swedish government has initiated a national reform to standardize cancer patient pathways and thereby eventually speed up treatment of cancer. Cancer care in Sweden is characterized by high survival rates and a generally high quality albeit long waiting times. The objective with the new national program to standardize cancer care pathways is to reduce these waiting times, increase patient satisfaction with cancer care and reduce regional inequalities. A new time-point for measuring the start of a care process is introduced called well-founded suspicion, which is individually designed for each cancer diagnosis. While medical guidelines are well established earlier, the standardisation is achieved by defining time boundaries for each step in the process. The cancer reform program is a collaborative effort initiated and incentivized by the central government while multi-professional groups develop the time-bound standardized care pathways, which the regional authorities are responsible for implementing. The broad stakeholder engagement and time-bound guidelines are interesting approaches to study for other countries that need to streamline care processes. Copyright Â
© 2016 The Author(s). Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Benchmarking; Clinical pathways; Continuity of patient care; Government programs; Health care reform; Standardized; Sweden; Waiting list

Mesh:

Year:  2016        PMID: 27823827     DOI: 10.1016/j.healthpol.2016.09.008

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  18 in total

1.  Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer.

Authors:  Sherri Sheinfeld Gorin
Journal:  Ann Fam Med       Date:  2019-09       Impact factor: 5.166

Review 2.  Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Authors:  Elizabeth M Adkins; Lindsay Nicholson; David Floyd; Mark Ratcliffe; Helene Chevrou-Severac
Journal:  Clinicoecon Outcomes Res       Date:  2017-06-10

3.  When complexity science meets implementation science: a theoretical and empirical analysis of systems change.

Authors:  Jeffrey Braithwaite; Kate Churruca; Janet C Long; Louise A Ellis; Jessica Herkes
Journal:  BMC Med       Date:  2018-04-30       Impact factor: 8.775

4.  Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

Authors:  Yngvar Nilssen; Odd Terje Brustugun; Morten Tandberg Eriksen; Erik Skaaheim Haug; Bjørn Naume; Bjørn Møller
Journal:  BMC Cancer       Date:  2020-05-30       Impact factor: 4.430

5.  Patients' experiences of using an e-Health tool for self-management support after prostate cancer surgery: a deductive interview study explained through the FITT framework.

Authors:  Lina Nilsson; Amanda Hellström; Camilla Wennerberg; Mirjam Ekstedt; Kristina Schildmeijer
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

6.  Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals.

Authors:  Sara Delilovic; Henna Hasson; Mårten Åhström; Mia von Knorring
Journal:  BMC Health Serv Res       Date:  2019-08-16       Impact factor: 2.655

7.  Patients' initial steps to cancer diagnosis in Denmark, England and Sweden: what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors?

Authors:  John MacArtney; Marlene Malmström; Trine Overgaard Nielsen; Julie Evans; Britt-Marie Bernhardson; Senada Hajdarevic; Alison Chapple; Lars E Eriksson; Louise Locock; Birgit Rasmussen; Peter Vedsted; Carol Tishelman; Rikke Sand Andersen; Sue Ziebland
Journal:  BMJ Open       Date:  2017-11-19       Impact factor: 2.692

8.  Negotiating bodily sensations between patients and GPs in the context of standardized cancer patient pathways - an observational study in primary care.

Authors:  Cecilia Hultstrand; Anna-Britt Coe; Mikael Lilja; Senada Hajdarevic
Journal:  BMC Health Serv Res       Date:  2020-01-17       Impact factor: 2.655

9.  Trends in time to cancer diagnosis around the period of changing national guidance on referral of symptomatic patients: A serial cross-sectional study using UK electronic healthcare records from 2006-17.

Authors:  Sarah Price; Anne Spencer; Xiaohui Zhang; Susan Ball; Georgios Lyratzopoulos; Ruben Mujica-Mota; Sal Stapley; Obioha C Ukoumunne; Willie Hamilton
Journal:  Cancer Epidemiol       Date:  2020-09-09       Impact factor: 2.984

10.  Improvement of the experience of colorectal cancer patients in Sweden with a regional cancer plan.

Authors:  A Sjövall; L Söderqvist; A Martling; C Buchli
Journal:  Colorectal Dis       Date:  2020-08-28       Impact factor: 3.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.